* Sees Q4 rev of $31.5 mln, down 52 pct
* Cites fall in sales of flu products
* Shares down 8 pct after mkt
Jan 5 Quidel Corp (QDEL.O), a provider of rapid
diagnostic tests, forecast lower-than-expected quarterly
revenue, citing a significant fall in sales of its influenza
products, sending its shares down 8 percent after market.
For the quarter ended Dec. 31 the company sees revenue of
about $31.5 million, down 52 percent, it said in a regulatory
Analysts on average had expected revenue of $37.5 million,
according to Thomson Reuters I/B/E/S.
Shares of Quidel, which have gained about 27 percent since
the company reported quarterly results in October, were down at
$13.35 in extended trade.
(Reporting by Rajarshi Basu in Bangalore; Editing by